OneMedNet (ONMD)
Curates de-identified imaging and patient data for life-sciences research.
Something off on this page? Send us feedback.
Curates de-identified, regulatory-grade imaging real-world data and related patient records for life-sciences customers. Its iRWD platform matches provider archives to research protocols and operates through a federated provider network.
Curates regulatory-grade imaging real-world data, combining clinical images with contextual patient records for life-sciences research. The iRWD platform obtains, de-identifies, searches, and curates provider archives into protocol-matched datasets, then serves research opportunities through a federated provider network.
Rather than providing imaging care, the model turns providers' archived images and linked records into research datasets. It gives life-sciences customers access to de-identified imaging material matched to research protocols.
Operates with a quality-management program centered on data quality, de-identification, and compliance controls. Its documented requirements include FDA 21 CFR Part 11; ongoing internal audits and policy reviews shape clinical-data handling.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $358.0K · Total debt $701.0K · Total assets $1.4M · Shareholders' equity −$3.5M
- Revenue
- $292.0K
- Operating income
- −$2.3M
- Net income
- −$2.2M
No dividends on record.
| Institutions21 holders · as of Mar 31, 2026 | 18.15% | 10.76M shares | |
| Insiders9 holders · as of Aug 7, 2026 | 53.64% | 31.80M shares | |
| Otherremainder | 28.21% | 16.72M shares |
59.29M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Thomas KosasaInsiderdirector, 10 percent owner | 31.27% | 18.54M | Form 4filed Aug 7, 2026 ↗ |
Jeffrey YuInsiderdirector, 10 percent owner, officer: Chief Medical Officer | 17.02% | 10.09M | Form 4filed Jun 24, 2026 ↗ |
Exencial Wealth Advisors, LLCInstitution | 14.13% | 8.38M | 13Fas of Mar 31, 2026 |
TD Securities (USA) LLCInstitution | 5.10% | 3.03M | 13Gfiled Nov 14, 2025 ↗ |
Aaron GreenInsiderdirector, officer: Chief Executive Officer | 3.20% | 1.90M | Form 4filed Jun 24, 2026 ↗ |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 30, 2026 | Thomas Kosasa | director, 10 percent owner: | +1,449,275 | $0.6900 |
| Jun 23, 2026 | Jeffrey Yu | director, 10 percent owner, officer: Chief Medical Officer | +158,730 | $0.6300 |
| Jun 23, 2026 | Aaron Green | director, officer: Chief Executive Officer | +36,650 | $0.5733 |
| Jun 16, 2026 | Jeffrey Yu | director, 10 percent owner, officer: Chief Medical Officer | +172,414 | $0.5800 |
| Jun 12, 2026 | Aaron Green | director, officer: Chief Executive Officer | +36,920 | $0.5581 |
- IQVIA
Life-sciences real-world data and evidence services at global scale
- ICON
Real-world evidence and clinical-trial imaging services for life sciences
- Tempus AI
De-identified multimodal oncology data and AI for therapeutic development
- Veeva Systems
Life-science patient data and data-cloud services
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| OneMedNet | $0.5750 | −0.33% | $32.3M | — | — | 22.2 | +88.4% |
| IQVIA | $264.50 | +0.23% | $43.43B | 32.7 | 19.4 | 2.6 | +8.7% |
| ICON | $160.49 | +0.42% | $12.24B | 37.5 | 14.3 | 1.5 | +2.3% |
| Tempus AI | $62.05 | +0.23% | $10.85B | — | — | 7.6 | +21.6% |
| Veeva Systems | $282.00 | +0.42% | $45.60B | 46.2 | 29.1 | 13.2 | +17.6% |
| Median | 37.5 | 19.4 | 5.1 | +13.2% |